1. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion;Eisenhauer;Journal of Clinical Oncology,1994
2. Essai randomisÚ europÚen et canadien comparent 2 doses et 2 durÚes de perfusion de Taxol chez des patientes traitÚes pour cancer de l'ovarie (CO) rÚsistant au platine. (ABSTRACT);LhommÚ;Bulletin du cancer,1994
3. Taxol in relapsed ovarian cancer: high vs low dose and short vs long infusion;Swenerton;Proceedings of the American Society of Clinical Oncology,1993
4. Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated Ovarian cancer. Canadian-European Taxol Cooperative Trial Group A2 - 0305-7372;Bokkel Huinink;Cancer Treatment Reviews,1993
5. Toxicity of taxol: a European-Canadian trial of high vs low dose and short vs long infusion in ovarian cancer coordinated by the NCI Canada clinical trials group (NCIC CTG);Bokkel Huinink;Annals of Oncology,1992